BioSpace News Archive

Business

Bicycle Therapeutics Announces Expansion of Genentech Immuno-Oncology Collaboration

Bicycle Therapeutics plc today announced that Genentech, a member of the Roche Group, has exercised an option to initiate a new program, expanding the exclusive strategic collaboration agreement with Bicycle to discover, develop and commercialize novel Bicycle®-based immuno-oncology therapies.

October 26, 2021
·
4 min read
Drug Development

BlueWillow Biologics to Present During BARDA Industry Day 2021

BlueWillow Biologics, Inc. today announced that the company will present positive interim data from its phase 1 clinical trial of a novel intranasal anthrax vaccine at a Lightning Talks Session of BARDA’s Industry Day, November 3 and 4, 2021.

October 26, 2021
·
1 min read
Drug Development

Seres Therapeutics Presents Late-Breaking Phase 3 Data on Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection at American College of Gastroenterology 2021 Annual Scientific Meeting

Seres Therapeutics Presents Late-Breaking Phase 3 Data on Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection at American College of Gastroenterology 2021 Annual Scientific Meeting

October 26, 2021
·
6 min read
Lone Star Bio

New Data Demonstrating Accuracy of DecisionDx® DiffDx™-Melanoma Presented at ASDP 58th Annual Meeting

New Data Demonstrating Accuracy of DecisionDx ® DiffDx ™ -Melanoma Presented at ASDP 58th Annual Meeting

October 26, 2021
·
7 min read
Business

Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance

Novozymes delivered 7% organic sales growth in the third quarter and 6% organic sales growth in the first nine months of 2021.

October 26, 2021
·
3 min read
Business

Aptose to Report Third Quarter 2021 Financial Results and Hold Conference Call on Thursday, November 11, 2021

Aptose Biosciences Inc. will report financial results for the quarter ended September 30, 2021, and provide a corporate update on Thursday, November 11, 2021, after the close of the market.

October 26, 2021
·
2 min read
Genetown

Moderna Announces Memorandum of Understanding to Supply up to 110 Million Doses of Its COVID-19 Vaccine to the African Union

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced a new Memorandum of Understanding to make up to 110 million doses of the Moderna COVID-19 vaccine available to the African Union.

October 26, 2021
·
4 min read
Protein A Resin Market: Increasing investments for protein-based research is one of the key factors driving the market

The protein A resin market is predicted to rise at a notable pace in the forthcoming years, with growing research in monoclonal antibodies being a primary factor.

October 26, 2021
·
5 min read